98 related articles for article (PubMed ID: 1584182)
1. Magnetic resonance imaging in parkinsonism.
Olanow CW
Neurol Clin; 1992 May; 10(2):405-20. PubMed ID: 1584182
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging and spectroscopy in Parkinson's disease.
Martin WR
Adv Neurol; 2001; 86():197-203. PubMed ID: 11553978
[TBL] [Abstract][Full Text] [Related]
3. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
[TBL] [Abstract][Full Text] [Related]
4. Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation.
Raff U; Hutchinson M; Rojas GM; Huete I
Acad Radiol; 2006 Jun; 13(6):721-7. PubMed ID: 16679274
[TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance imaging of parkinsonism].
Mukai E; Makino N; Fujishiro K
Rinsho Shinkeigaku; 1989 Jun; 29(6):720-5. PubMed ID: 2582685
[TBL] [Abstract][Full Text] [Related]
6. [Morphological magnetic resonance imaging: its value for the diagnosis of neurodegenerative diseases].
Hahn U; Schwarz J; Gratz S; Kaiser JW; Jarnig M; Förstl H
Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S15-8. PubMed ID: 18437637
[TBL] [Abstract][Full Text] [Related]
7. Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts.
Michaeli S; Oz G; Sorce DJ; Garwood M; Ugurbil K; Majestic S; Tuite P
Mov Disord; 2007 Feb; 22(3):334-40. PubMed ID: 17149719
[TBL] [Abstract][Full Text] [Related]
8. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE
Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421
[TBL] [Abstract][Full Text] [Related]
9. [A 74-year-old woman with parkinsonism and dementia who died four years after the onset].
Okuma Y; Hattori N; Nobukawa B; Mori H; Suda K; Takubo H; Mizuno Y
No To Shinkei; 1998 Jul; 50(7):671-82. PubMed ID: 9739528
[TBL] [Abstract][Full Text] [Related]
10. MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice.
Seppi K
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S400-5. PubMed ID: 18267272
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
Geng DY; Li YX; Zee CS
Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
13. Potential role of high-field MRI for studies in Parkinson's disease.
Schuff N
Mov Disord; 2009; 24 Suppl 2():S684-90. PubMed ID: 19877239
[TBL] [Abstract][Full Text] [Related]
14. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.
Martin WR; Wieler M; Gee M
Neurology; 2008 Apr; 70(16 Pt 2):1411-7. PubMed ID: 18172063
[TBL] [Abstract][Full Text] [Related]
15. Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism.
Brar S; Henderson D; Schenck J; Zimmerman EA
Arch Neurol; 2009 Mar; 66(3):371-4. PubMed ID: 19273756
[TBL] [Abstract][Full Text] [Related]
16. Presymptomatic detection of Parkinson's disease.
Jenner P
J Neural Transm Suppl; 1993; 40():23-36. PubMed ID: 8294898
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance relaxometry in Parkinson's disease.
Mondino F; Filippi P; Magliola U; Duca S
Neurol Sci; 2002 Sep; 23 Suppl 2():S87-8. PubMed ID: 12548357
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility-weighted imaging in detecting brain iron accumulation of Parkinson's disease].
Huang XM; Sun B; Xue YJ; Duan Q
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(43):3054-8. PubMed ID: 21211325
[TBL] [Abstract][Full Text] [Related]
19. Parkinsonism and multiple sclerosis--is there association?
Barun B; Brinar VV; Zadro I; Lusić I; Radović D; Habek M
Clin Neurol Neurosurg; 2008 Nov; 110(9):958-61. PubMed ID: 18482794
[TBL] [Abstract][Full Text] [Related]
20. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
